| Role of ferroptosis in cisplatin-induced acute nephrotoxicity in mice Y Ikeda, H Hamano, Y Horinouchi, L Miyamoto, T Hirayama, H Nagasawa, ... Journal of Trace Elements in Medicine and Biology 67, 126798, 2021 | 66 | 2021 |
| The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease H Hamano, Y Ikeda, H Watanabe, Y Horinouchi, Y Izawa-Ishizawa, ... Nephrology Dialysis Transplantation 33 (4), 586-597, 2018 | 51 | 2018 |
| Diphenhydramine may be a preventive medicine against cisplatin-induced kidney toxicity H Hamano, Y Ikeda, M Goda, K Fukushima, S Kishi, M Chuma, ... Kidney international 99 (4), 885-899, 2021 | 47 | 2021 |
| Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3–E3 ubiquitin ligase-dependent pathway Y Ikeda, M Imao, A Satoh, H Watanabe, H Hamano, Y Horinouchi, ... Journal of Trace Elements in Medicine and Biology 35, 66-76, 2016 | 47 | 2016 |
| Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway H Hamano, T Niimura, Y Horinouchi, Y Zamami, K Takechi, M Goda, ... Toxicology Letters 318, 86-91, 2020 | 43 | 2020 |
| Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress Y Ikeda, A Satoh, Y Horinouchi, H Hamano, H Watanabe, M Imao, ... The FASEB Journal 33 (8), 9551-9564, 2019 | 41 | 2019 |
| Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis Y Horinouchi, Y Ikeda, K Fukushima, M Imanishi, H Hamano, ... Scientific reports 8 (1), 10858, 2018 | 38 | 2018 |
| Deletion of H-ferritin in macrophages alleviates obesity and diabetes induced by high-fat diet in mice Y Ikeda, H Watanabe, T Shiuchi, H Hamano, Y Horinouchi, M Imanishi, ... Diabetologia 63, 1588-1602, 2020 | 35 | 2020 |
| Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice Y Ikeda, Y Horinouchi, H Hamano, T Hirayama, S Kishi, Y Izawa-Ishizawa, ... Scientific reports 7 (1), 10621, 2017 | 34 | 2017 |
| Iron suppresses erythropoietin expression via oxidative stress-dependent hypoxia-inducible factor-2 alpha inactivation K Oshima, Y Ikeda, Y Horinouchi, H Watanabe, H Hamano, Y Kihira, ... Laboratory investigation 97 (5), 555-566, 2017 | 24 | 2017 |
| Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database H Hamano, M Mitsui, Y Zamami, K Takechi, T Nimura, N Okada, ... Supportive Care in Cancer 27, 849-856, 2019 | 21 | 2019 |
| Bilirubin exerts pro-angiogenic property through Akt-eNOS-dependent pathway Y Ikeda, H Hamano, A Satoh, Y Horinouchi, Y Izawa-Ishizawa, Y Kihira, ... Hypertension Research 38 (11), 733-740, 2015 | 21 | 2015 |
| Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database N Okada, T Niimura, Y Zamami, H Hamano, S Ishida, M Goda, K Takechi, ... Cancer medicine 8 (1), 174-181, 2019 | 19 | 2019 |
| Association between statin use and daptomycin-related musculoskeletal adverse events: a mixed approach combining a meta-analysis and a disproportionality analysis M Chuma, A Nakamoto, T Bando, T Niimura, Y Kondo, H Hamano, ... Clinical infectious diseases 75 (8), 1416-1422, 2022 | 18 | 2022 |
| Effects of 5‐HT₃ receptor antagonists on cisplatin‐induced kidney injury M Goda, M Kanda, T Yoshioka, A Yoshida, Y Murai, Y Zamami, F Aizawa, ... Clinical and Translational Science 14 (5), 1906-1916, 2021 | 16 | 2021 |
| Investigation of drugs affecting hypertension in bevacizumab‐treated patients and examination of the impact on the therapeutic effect K Yagi, M Mitstui, Y Zamami, T Niimura, Y Izawa‐Ishizawa, M Goda, ... Cancer medicine 10 (1), 164-172, 2021 | 16 | 2021 |
| Evaluation of potential complications of interstitial lung disease associated with antiandrogens using data from databases reporting spontaneous adverse effects H Nawa, T Niimura, H Hamano, K Yagi, M Goda, Y Zamami, K Ishizawa Frontiers in Pharmacology 12, 655605, 2021 | 15 | 2021 |
| Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study N Okada, M Chuma, M Azuma, S Nakamura, H Miki, H Hamano, M Goda, ... European Journal of Clinical Pharmacology 75, 1695-1704, 2019 | 14 | 2019 |
| Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data Y Zamami, T Niimura, T Kawashiri, M Goda, Y Naito, K Fukushima, ... Biomedicine & Pharmacotherapy 148, 112744, 2022 | 13 | 2022 |
| Drug-repositioning approaches based on medical and life science databases Y Zamami, H Hamano, T Niimura, F Aizawa, K Yagi, M Goda, ... Frontiers in Pharmacology 12, 752174, 2021 | 13 | 2021 |
